Waltham, MA – According to filings with the U.S. Securities and Exchange Commission, InterWell Health is raising $46,110,805.00 in new funding. Sources indicate as part of senior management Chief Medical Officer, George Hart played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About InterWell Health

We are a national physician organization dedicated to delivering value and driving innovation for renal patients, providers, and payors. Our unique approach assists providers as they address the needs of public and private payors to manage renal patient populations across the full continuum of chronic kidney disease, transplant, end stage renal disease, and conservative care. The result is innovative care for renal patients with improvements in clinical outcomes and patient quality of life. InterWell Health combines the expertise of a diverse and preeminent group of nephrology practices with the experience of Fresenius Medical Care North America to advance value based contracting models that are attractive to medical staff, payors, and patients by driving better clinical outcomes at lower costs. We establish best practices and set expectations to drive optimal clinical performance across a variety of value based arrangements. Our value extends across our national, high-performing renal network, allowing all nephrologists to have an opportunity to participate in value based arrangements.

To learn more about InterWell Health, visit http://www.interwellhealth.com/

Contact:
George Hart, Chief Medical Officer
781-699-9000
ghart@interwellhealth.com
https://www.linkedin.com/in/dr-george-hart-19b06373/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved